145
Xu J#, Cao B*. Letter from China: Managing the second-wave COVID-19 outbreak in Beijing. Respirology. 2021 Jan 5. doi: 10.1111/resp.14002. Online ahead of print.
146
Liu S#, Huang Z#, Deng X, Zou X, Li H, Mu S, Cao B*. Identification of key candidate biomarkers for severe influenza infection by integrated bioinformatical analysis and initial clinical validation. J Cell Mol Med. 2021 Jan 14. doi: 10.1111/jcmm.16275. Online ahead of print.
147
Li H#, Gu X#, Li H#, Gong F#, Xu J, Wang Y, Li H, Ruan S, Yang Q, Cao B*. Risk factors of viral RNAaemia and its association with clinical prognosis among patients with severe COVID-19. Chest. 2021 Jan 6;S0012-3692(21)00007-6. doi: 10.1016/j.chest.2020.11.071.
149
李丽娟﹟,黎斌斌,王一民,王春雷,孙凌霄,刘颖梅,鲁炳怀,曹彬*.成人副流感病毒下呼吸道感染患者临床特征和预后分析[J].中华医学杂志,2020,100(27):2109-2115.
151
李丽娟﹟,刘思危,孙凌霄,王一民,刘颖梅,王金祥,任亚莉,刘波,潘建亮,刘菲菲,宋丽斯,王传,曹彬*.成人鼻病毒肺炎临床特征和混合感染病原学特点分析[J].中国呼吸与危重监护杂志,2020,19(05):451-456.
153
Carlos WG, Cruz CSD, Cao B, Gross JE, Pasnick S, Jamil S. COVID-19: How Do We Stay Safe? Am J Respir Crit Care Med. 2020 Sep 1;202(5):P15-P16. doi: 10.1164/rccm.2025P15.
154
Han X﹟*, Liu X, Chen L, Wang Y, Li H, Zhou F, Xing X, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu M, Xue C, Liu B, Zhu X, Li Y, Xiao Y, Cui X, Li L, Cao B; CAP-China network. Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients. BMC Infect Dis. 2020 Sep 12;20(1):668. doi: 10.1186/s12879-020-05362-3.
155
Shang L﹟, Gu X﹟, Du S, Wang Y, Cao B*, Wang C*; CAP-China Network. The efficacy and safety of therapeutic lung lavage for exogenous lipoid pneumonia: a systematic review. Clin Respir J. 2020 Sep 17. doi: 10.1111/crj.13273. Epub ahead of print.
156
Wang Y﹟, Gu X, Xu J, Cao B*, Wang C. Remdesivir and COVID-19 - Authors' reply. Lancet. 2020 Oct 3;396(10256):954. doi: 10.1016/S0140-6736(20)32015-8.
157
Cao B﹟*, Hayden FG. Antiviral monotherapy for hospitalised patients with COVID-19 is not enough. Lancet. 2020 Oct 5;396(10259):1310–1. doi: 10.1016/S0140-6736(20)32078-X. Epub ahead of print.
158
Xu J﹟, Teng Y﹟, Shang L﹟, Gu X, Fan G, Chen Y, Tian R, Zhang S, Cao B*. The Effect of Prior ACEI/ARB Treatment on COVID-19 Susceptibility and Outcome: A Systematic Review and Meta-Analysis. Clin Infect Dis. 2020 Oct 20:ciaa1592. doi: 10.1093/cid/ciaa1592. Epub ahead of print.
159
Sun Y﹟, Li H﹟, Pei Z, Wang S, Feng J, Xu L, Gao P, Cao B,* Zhan S*. Incidence of community-acquired pneumonia in urban China: A national population-based study. Vaccine. 2020 Dec 14;38(52):8362-8370. doi: 10.1016/j.vaccine.2020.11.004. Epub 2020 Nov 13.
160
Zhang Y﹟, Li Y, Zeng J, Chang Y, Han S, Zhao J, Fan Y, Xiong Z, Zou X, Wang C, Li B, Li H, Han J, Liu X, Xia Y, Lu B*, Cao B*. Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality. Infect Drug Resist. 2020 Nov 12;13:4115-4123. doi: 10.2147/IDR.S268744.
